1. Home
  2. INAB vs REBN Comparison

INAB vs REBN Comparison

Compare INAB & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • REBN
  • Stock Information
  • Founded
  • INAB 2016
  • REBN 2015
  • Country
  • INAB United States
  • REBN United States
  • Employees
  • INAB N/A
  • REBN N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • INAB Health Care
  • REBN Consumer Discretionary
  • Exchange
  • INAB Nasdaq
  • REBN Nasdaq
  • Market Cap
  • INAB 10.6M
  • REBN 9.4M
  • IPO Year
  • INAB 2021
  • REBN 2022
  • Fundamental
  • Price
  • INAB $1.63
  • REBN $1.51
  • Analyst Decision
  • INAB Strong Buy
  • REBN
  • Analyst Count
  • INAB 2
  • REBN 0
  • Target Price
  • INAB $108.00
  • REBN N/A
  • AVG Volume (30 Days)
  • INAB 72.9K
  • REBN 78.7K
  • Earning Date
  • INAB 11-06-2025
  • REBN 11-14-2025
  • Dividend Yield
  • INAB N/A
  • REBN N/A
  • EPS Growth
  • INAB N/A
  • REBN N/A
  • EPS
  • INAB N/A
  • REBN N/A
  • Revenue
  • INAB N/A
  • REBN $6,565,623.00
  • Revenue This Year
  • INAB N/A
  • REBN $335.98
  • Revenue Next Year
  • INAB N/A
  • REBN N/A
  • P/E Ratio
  • INAB N/A
  • REBN N/A
  • Revenue Growth
  • INAB N/A
  • REBN 14.03
  • 52 Week Low
  • INAB $1.53
  • REBN $1.04
  • 52 Week High
  • INAB $12.53
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • INAB 32.35
  • REBN 31.55
  • Support Level
  • INAB $1.53
  • REBN $1.44
  • Resistance Level
  • INAB $1.77
  • REBN $1.73
  • Average True Range (ATR)
  • INAB 0.17
  • REBN 0.12
  • MACD
  • INAB -0.02
  • REBN -0.02
  • Stochastic Oscillator
  • INAB 12.28
  • REBN 12.82

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: